ADVANSE Virtual Pitch Rounds: COVID-19
About ADVANSE Virtual Pitch Round...
Calling All Southeast Life Science Innovators: If your early-stage or seed-stage company is innovating in the life sciences space impactful to COVID-19 solutions, we want to see your pitch!
While our annual ADVANSE Life Sciences Conference and SE PitchRounds competition has been postponed, we are not standing still in fulfilling our mission to support and promote life science innovation in the Southeast.
Whether your company is in biopharma, medical devices, diagnostics, or digital health, all are welcome to apply to demonstrate their company’s potential in providing life-saving or treatment-enhancing solutions for our healthcare system.
This pitch competition will be held virtually, and participants will benefit from exposure through the competition and beyond to a range of life science investors interested in the Southeast as well as other innovation professionals. Held in a format close to a live, in-person presentation, your pitch will be viewed with the same criteria as a regular pitch. Past presenters at our annual conferences have included more than 400 companies which collectively attracted 500 distinct investors, raised more than $5.2B in funding in more than 800 transactions, including 9 IPOs and 19 M&As.
About Southeast Life Sciences: In November Southeast BIO and the Southeast Medical Device Association merged, forming Southeast Life Sciences. The combination resulted in a unified voice for the region’s life science industry. The mission of Southeast Life Sciences is to efficiently, effectively connect our industry’s innovators and entrepreneurs with the right investment and partners be they institutions, corporations, venture capitalists or angels. We facilitate connections, conversations and capital investments through continuous networking, education and funding opportunities for life-science innovators of all shapes and sizes.
We're not connecting right now - follow us to keep updated